Yvette van Norden
Overview
Explore the profile of Yvette van Norden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
613
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hermans S, van der Maas N, van Norden Y, Dinmohamed A, Berkx E, Huijgens P, et al.
JAMA Oncol
. 2024 Aug;
10(10):1426-1436.
PMID: 39207765
Importance: The use of real-world data (RWD) external control arms in prospective studies is increasing. The advantages, including the immediate availability of a control population, must be balanced with the...
2.
Hermans S, van Norden Y, Versluis J, Rijneveld A, van der Holt B, de Weerdt O, et al.
Cancer Med
. 2024 Apr;
13(9):e6756.
PMID: 38680089
Background: We recently reported results of the prospective, open-label HOVON-100 trial in 334 adult patients with acute lymphoblastic leukemia (ALL) randomized to first-line treatment with or without clofarabine (CLO). No...
3.
Verduijn G, Sijtsema N, van Norden Y, Heemsbergen W, Mast H, Sewnaik A, et al.
Radiother Oncol
. 2023 Dec;
190:110036.
PMID: 38040122
No abstract available.
4.
Verduijn G, Sijtsema N, van Norden Y, Heemsbergen W, Mast H, Sewnaik A, et al.
Radiother Oncol
. 2023 Sep;
188:109889.
PMID: 37659662
Background And Purpose: Osteoradionecrosis (ORN) of the mandible is a severe complication following radiotherapy (RT). With a renewed interest in hypofractionation for head and neck radiotherapy, more information concerning ORN...
5.
Sijtsema N, Verduijn G, Nasserinejad K, van Norden Y, Mast H, van der Lugt A, et al.
Radiother Oncol
. 2023 Jun;
186:109736.
PMID: 37315578
Purpose: Osteoradionecrosis (ORN) of the mandible is a severe complication following radiotherapy of the head and neck, but not all regions of the mandible may be equally at risk. Therefore...
6.
Elbers J, Gunsch P, Debets R, Keereweer S, van Meerten E, Zindler J, et al.
BMC Cancer
. 2023 Jun;
23(1):541.
PMID: 37312053
Background: Radiotherapy (RT) is the standard of care for most advanced head and neck squamous cell carcinoma (HNSCC) and results in an unfavorable 5-year overall survival of 40%. Despite strong...
7.
Jaspers J, Taal W, van Norden Y, Zindler J, Swaak A, Habraken S, et al.
Radiother Oncol
. 2023 Apr;
184:109674.
PMID: 37084885
Objective: The interpretation of new enhancing lesions after radiotherapy for diffuse glioma remains a clinical challenge. We sought to characterize and classify new contrast enhancing lesions in a historical multicenter...
8.
Paronetto C, den Toom W, Milder M, van Norden Y, Baak R, Heijmen B, et al.
Front Oncol
. 2023 Mar;
13:1114737.
PMID: 36969072
Using fiducial-marker-based robotic respiratory tumor tracking, we treated perihilar cholangiocarcinoma patients in the STRONG trial with 15 daily fractions of 4 Gy. For each of the included patients, in-room diagnostic-quality...
9.
Hermans S, Versluis J, Labopin M, Giebel S, van Norden Y, Moiseev I, et al.
Hemasphere
. 2023 Feb;
7(3):e846.
PMID: 36844179
Graft versus host disease (GVHD) prophylaxis with posttransplantation cyclophosphamide (PTCY) has been established to reduce severe GVHD, and thereby potentially reducing nonrelapse mortality (NRM) after allogeneic stem cell transplantation (alloSCT)....
10.
Verduijn G, Petit S, Lauwers I, van Norden Y, Sijtsema N, Sewnaik A, et al.
Acta Oncol
. 2022 Dec;
62(1):40-47.
PMID: 36576773
Background/purpose: Post radiation mucosal ulcers (PRMU) after treatment for oropharyngeal squamous cell carcinoma (OPSCC) can have a huge negative impact on patients' quality of life, but little is known concerning...